1. News

Myeloproliferative Disorders Drugs Market Expert Guide to Boost the Industry in Global Market Share

Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

The global myeloproliferative disorders drugs market size is projected to expand at a high CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increased awareness of myeloproliferative disorders worldwide as well as early diagnosis along with rise in focus on research and development activities by key players.

Haematological abnormalities of the bone marrow and blood cells are known as myeloproliferative disorders. It occurs when scar tissue builds up inside the bone marrow, resulting in inadequate blood cell production. The existing medications are not sufficient for disease-modifying activity and they are still inadequate for addressing significant unmet requirements such as preventing haematological progression and reducing cardiovascular consequences. Rising unmet market needs present a significant opportunity to produce ground-breaking first-in-class medicines and provide effective future therapy landscape for myeloproliferative diseases. Despite the market low growth, several firms are continuing to evaluate novel therapeutic techniques and combination regimens that could potentially improve treatment outcomes.

Market Segment Insights

Based on indications, the myeloproliferative disorders market is bifurcated into Ph+ chronic myelogenous leukemia (CML) and Ph- myeloproliferative neoplasms (MPNs). The MPNs segment is further divided into myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia (ET). The polycythemia vera segment is expected to account for a key share of the market in the coming years owing to wide prevalence of myeloproliferative diseases in North America and Western Europe, with the lowest prevalence in East Asia. MPNs are most commonly diagnosed in persons over the age of 60; however, the disease can strike anyone at any age. Primary myelofibrosis (PMF) and myelofibrosis transformation from preceding polycythemia vera (post-PV MF) or essential thrombocytosis are all types of myelofibrosis (post-ET MF). Polycythemia vera (PV) is a condition in which red blood cells proliferate constantly. An increase in hemoglobin causes an increase in blood volume and viscosity, as well as an increased risk of thrombosis. A rise in platelet count and a proclivity for vascular occlusive events and bleeding describe essential thrombocythemia (ET). CML is a myeloproliferative neoplasm marked by uncontrolled granulocyte proliferation and the presence of the BCR-ABL1 fusion gene on the Philadelphia chromosome.

Get Sample Report @ Request For Sample of Myeloproliferative Disorders Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast | Growth Market Reports

On the basis of regions, the market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Europe is anticipated to dominate the market by exhibiting an impressive CAGR during the forecast period. The presence of a large targeted population, many product launches, and increased adoption of innovative therapies by a large number of patients are among the key growth drivers for the regional market growth. Germany is currently the leading country representing the top five EU markets. Over the forecast period, the markets in the United Kingdom, Italy, and France are expected to rise moderately.

Key Players Covered in the Report

Novartis AG; Bristol-Myers Squibb Company; Pfizer Inc.; Takeda Pharmaceutical Company Limited; Incyte Corporation; and Teva Pharmaceutical Industries Ltd.

About Growth Market Reports:

Growth Market Reports provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. Growth Market Reports has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys.


Growth Market Reports
Phone: +1 909 414 1393
Email: sales@growthmarketreports.com
Web: https://growthmarketreports.com
Follow Us: LinkedIn | Twitter




Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe